Literature DB >> 23436097

Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication.

Marzio Frazzoni1, Micaela Piccoli, Rita Conigliaro, Raffaele Manta, Leonardo Frazzoni, Gianluigi Melotti.   

Abstract

BACKGROUND: Some patients with typical (heartburn/regurgitation) symptoms of gastroesophageal reflux disease (GERD) are refractory to proton pump inhibitor (PPI) therapy. Impedance-pH monitoring can identify PPI-refractory patients who could benefit from laparoscopic fundoplication, but outcome data are scarce. We aimed to assess whether PPI-refractory GERD as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication.
METHODS: Forty-four consecutive GERD patients with heartburn/regurgitation refractory to high-dose PPI therapy entered a 3-year outcome assessment following robot-assisted laparoscopic fundoplication. Preoperative on-PPI impedance-pH diagnostic criteria consisted of positive symptom association probability (SAP)/symptom index (SI), and/or abnormal percentage esophageal acid exposure time (%EAET), and/or abnormal number of total refluxes. GERD cure was defined by 3-year postoperative off-PPI normal impedance-pH findings with persistent symptom remission.
RESULTS: Preoperatively, 24 of 38 (63 %) patients who completed the outcome assessment had a positive SAP/SI, 20 of 38 (53 %) for weakly acidic refluxes; 3 of 38 (8 %) patients had an abnormal %EAET, 11 of 38 (29 %) an abnormal number of total refluxes only. Postoperatively, heartburn/regurgitation recurred in 3 patients; abnormal impedance-pH findings were found in two of them, and they responded to PPI therapy. GERD cure was achieved in 34 of 38 (89 %) patients, 11 of 11 with an abnormal number of total refluxes as the only preoperative abnormal impedance-pH finding. Postoperatively, there was a significant decrease of the %EAET (1 vs. 0.1 %, P = 0.002) and of the number of total refluxes (68 vs. 8, P = 0.001), with the latter finding mainly due to a decrease in the number of weakly acidic refluxes.
CONCLUSIONS: Normal reflux parameters and persistent symptom remission at 3-year follow-up can be achieved with laparoscopic fundoplication in the majority of patients with PPI-refractory GERD as diagnosed by impedance-pH monitoring. On-PPI impedance-pH diagnostic criteria should include SAP/SI positivity, an abnormal %EAET, and an abnormal number of total refluxes. Weakly acidic refluxes have a major role in the pathogenesis of PPI-refractory GERD.

Entities:  

Mesh:

Year:  2013        PMID: 23436097     DOI: 10.1007/s00464-013-2861-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  32 in total

1.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

Review 2.  Therapeutic options for refractory gastroesophageal reflux disease.

Authors:  Ronnie Fass
Journal:  J Gastroenterol Hepatol       Date:  2012-04       Impact factor: 4.029

Review 3.  Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.

Authors:  Daniel Sifrim; Frank Zerbib
Journal:  Gut       Date:  2012-06-08       Impact factor: 23.059

Review 4.  American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease.

Authors:  Peter J Kahrilas; Nicholas J Shaheen; Michael F Vaezi
Journal:  Gastroenterology       Date:  2008-09-16       Impact factor: 22.682

5.  Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD.

Authors:  M Frazzoni; R Conigliaro; R Manta; G Melotti
Journal:  Aliment Pharmacol Ther       Date:  2011-05-03       Impact factor: 8.171

6.  Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.

Authors:  I Mainie; R Tutuian; A Agrawal; D Adams; D O Castell
Journal:  Br J Surg       Date:  2006-12       Impact factor: 6.939

7.  Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison.

Authors:  M Frazzoni; A Grisendi; A Lanzani; G Melotti; E De Micheli
Journal:  Dig Liver Dis       Date:  2002-02       Impact factor: 4.088

8.  Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!

Authors:  Carmelo Scarpignato
Journal:  Neurogastroenterol Motil       Date:  2012-08       Impact factor: 3.598

9.  Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.

Authors:  Frank Zerbib; Sabine Roman; Alain Ropert; Stanislas Bruley des Varannes; Philippe Pouderoux; Ulriikka Chaput; François Mion; Eric Vérin; Jean-Paul Galmiche; Daniel Sifrim
Journal:  Am J Gastroenterol       Date:  2006-07-18       Impact factor: 10.864

10.  Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice.

Authors:  Bart P L Witteman; Rob Strijkers; Eva de Vries; Liza Toemen; José M Conchillo; Wim Hameeteman; Pieter C Dagnelie; Ger H Koek; Nicole D Bouvy
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

View more
  23 in total

Review 1.  Gastroesophageal reflux disease: A review of surgical decision making.

Authors:  Maureen Moore; Cheguevara Afaneh; Daniel Benhuri; Caroline Antonacci; Jonathan Abelson; Rasa Zarnegar
Journal:  World J Gastrointest Surg       Date:  2016-01-27

2.  Reply to "the importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing".

Authors:  Marzio Frazzoni; Micaela Piccoli; Rita Conigliaro; Raffaele Manta; Leonardo Frazzoni; Gianluigi Melotti
Journal:  Surg Endosc       Date:  2013-06-13       Impact factor: 4.584

3.  The importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing.

Authors:  Edoardo Savarino; Maria Giacchino; Vincenzo Savarino
Journal:  Surg Endosc       Date:  2013-07-12       Impact factor: 4.584

4.  Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach.

Authors:  Nicola de Bortoli; Irene Martinucci; Santino Marchi; Edoardo Savarino
Journal:  Surg Endosc       Date:  2013-08-31       Impact factor: 4.584

5.  Outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease in non-responders to proton pump inhibitors.

Authors:  Emad Hamdy; Ayman El Nakeeb; Hosam Hamed; Mohamed El Hemaly; Nabil Gad ElHak
Journal:  J Gastrointest Surg       Date:  2014-07-02       Impact factor: 3.452

6.  Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn.

Authors:  Marzio Frazzoni; Nicola de Bortoli; Leonardo Frazzoni; Manuele Furnari; Irene Martinucci; Salvatore Tolone; Andrea Farioli; Santino Marchi; Lorenzo Fuccio; Vincenzo Savarino; Edoardo Savarino
Journal:  J Gastroenterol       Date:  2016-05-30       Impact factor: 7.527

Review 7.  Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis.

Authors:  Nadja Rickenbacher; Thomas Kötter; Michael M Kochen; Martin Scherer; Eva Blozik
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

Review 8.  Laparoscopic fundoplication for gastroesophageal reflux disease.

Authors:  Marzio Frazzoni; Micaela Piccoli; Rita Conigliaro; Leonardo Frazzoni; Gianluigi Melotti
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

9.  Long-term results of electrical stimulation of the lower esophageal sphincter for treatment of proximal GERD.

Authors:  Toshitaka Hoppo; Leonardo Rodríguez; Edy Soffer; Michael D Crowell; Blair A Jobe
Journal:  Surg Endosc       Date:  2014-07-22       Impact factor: 4.584

Review 10.  Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease.

Authors:  L Hillman; R Yadlapati; M Whitsett; A J Thuluvath; M A Berendsen; J E Pandolfino
Journal:  Dis Esophagus       Date:  2017-09-01       Impact factor: 3.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.